Mustargen and Ear discomfort - a phase IV clinical study of FDA data
We study 9,884 people who take Mustargen or have Ear discomfort. No report of Ear discomfort is found in people who take Mustargen.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Mustargen?
Mustargen has active ingredients of mechlorethamine hydrochloride. eHealthMe is studying from 168 Mustargen users for its effectiveness, alternative drugs and more.
What is Ear Discomfort?
Ear discomfort is found to be associated with 1,855 drugs and 1,194 conditions by eHealthMe.
Do you take Mustargen and have Ear discomfort?Check whether Ear discomfort is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Ear discomfort and when was it recovered:
Expand to all the drugs that have ingredients of mechlorethamine hydrochloride:
Alternative drugs to, pros and cons of Mustargen:
- Mustargen (168 reports)
Ear discomfort treatments and more:
- Ear discomfort (9,716 reports)
COVID vaccines that are related to Ear discomfort:
- Ear discomfort in Moderna COVID Vaccine
- Ear discomfort in Pfizer BioNTech Covid Vaccine
- Ear discomfort in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Ear discomfort:
All the conditions that are associated with Ear discomfort:
How the study uses the data?
The study uses data from the FDA. It is based on mechlorethamine hydrochloride (the active ingredients of Mustargen) and Mustargen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Iron Overload and Blood Bilirubin Increased - 3 seconds ago
- Tudorza Pressair and Chantix drug interaction - 9 seconds ago
- Xgeva and Abscess Jaw - 18 seconds ago
- Vesicare and Lacunar Infarction - 18 seconds ago
- Triamterene And Hydrochlorothiazide and Pemoline drug interaction - 18 seconds ago
- Losartan vs. Niacin - 19 seconds ago
- Ribavarin and Fluoxetine drug interaction - 24 seconds ago
- Plaquenil and Cardiac Troponin I Increased - 27 seconds ago
- Ritalin and Diabetic Foot - 29 seconds ago
- Neurontin and Angina Unstable - 32 seconds ago